| Title: |
Stage I seminoma: Outcome of different treatment modalities and changes in patterns of care. A single institution experience. |
| Authors: |
Sayed, Manar Mahmoud1 Manar.mahmoud54@yahoo.com, Nasr, Azza Mohamad1 Nasrazza2@hotmail.com, Eldin, Ibtesam Mohamad Saad2 Ibtessamsaad@yahoo.com, Abdelazim, Yasser Anwar1 Yasser.anwar@nci.cu.edu.eg |
| Source: |
Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia. 2023, Vol. 95 Issue 1, p1-4. 4p. |
| Subject Terms: |
*SEMINOMA, *RADIOTHERAPY, *PROGRESSION-free survival, *WATCHFUL waiting, *ADJUVANT chemotherapy |
| Abstract: |
Background: The mainstay for management of stage I seminoma is high inguinal orchiectomy with post-orchiectomy therapeutic options including active surveillance, chemotherapy or radiation therapy. Objectives: To analyze different post-orchiectomy treatment modalities outcomes of stage I seminoma patients presented to NCI, Cairo University in the period from 2005-2019. Patients and methods: A retrospective review of all patients' records with clinical stage I seminoma who presented to our institute in the period from 2005-2019 was done. Adjuvant treatment details were extracted, and we compared overall survival (OS) and disease free survival (DFS) for different modalities and changes in patterns of care over this period. Results: Thirty-five patients were identified with thirty three patients eligible for analysis. Median age was 35 years (range, 19-52). Fourteen patients were kept under active surveillance, eleven patients received adjuvant carboplatin and eight patients received adjuvant radiation to para-aortic chain. Five-year OS was 100% for all patients regardless post-operative approach. Five-year DFS was 100% for patients who received adjuvant chemotherapy or radiotherapy versus 93% for patients who were kept under active surveillance (p = 0.03). Conclusions: Clinical stage I seminoma is a favorable disease entity with favorable disease related outcomes regardless postoperative approach. Active surveillance is reasonable and safe given equal survival to active treatment. [ABSTRACT FROM AUTHOR] |
|
Copyright of Archives of Italian Urology & Andrology / Archivio Italiano di Urologia Andrologia is the property of PAGEPress and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
